NTRA technical analysis
NTRA Technical Analysis
Analysis date
July 17, 2026
Market
NasdaqGS (USD)
Daily cutoff
July 16, 2026
Reliability
Passed
Informational use only. This page is not investment advice.
Data verification
NTRA Data Verification
Cross-validating the latest completed daily bar across independent sources.
- Symbol
- NTRA
- Market
- NasdaqGS
- Currency
- USD (US Dollar)
- Latest completed bar
- July 16, 2026
No adjustment factor (adjusted close equals raw close, factor 1.0). No stock splits or dividend adjustments affecting the analysis period.
| Source | Latest Close | Date | Difference | Status |
|---|---|---|---|---|
| Financial Modeling Prep (FMP, primary) | 191.42 | July 16, 2026 | - | Verified |
| Massive API (independent) | 191.42 | July 16, 2026 | 0.00% | Verified |
Bottom line
NTRA Technical Analysis Summary
NTRA (Natera) exhibits a strong bullish structure across both daily and weekly timeframes. On the daily chart, price at 191.42 trades comfortably above SMA20 (179.83), SMA50 (170.52), and SMA200 (137.76), confirming a well-established uptrend. RSI14 at 62.44 on the daily chart indicates healthy bullish momentum without reaching overbought territory. The daily MACD is positive with the MACD line at 5.26 above the signal line at 3.24 and a histogram at 2.02, reflecting sustained bullish momentum. The weekly timeframe confirms the structural uptrend with price at 189.15 above all key SMAs and RSI at 60.21. Key support levels are SMA20 (179.83) and the 20-day low (162.82). Key resistance lies at the 20-day high (197.22) and further out at the all-time high around 205. The stock is trading at the 87th percentile of its 52-week range, reflecting sustained institutional interest in the diagnostics space.
Multi-timeframe dashboard
Multi-Timeframe Technical Dashboard
Comparing daily (2-year) and weekly (5-year) perspectives to identify aligned or conflicting signals.
Daily (July 16, 2026)
- Trend
- Bullish and well-established. Price at 191.42 is above SMA20 (179.83, +6.45%), SMA50 (170.52, +12.27%), and SMA200 (137.76, +38.95%). All three SMAs are sloping upward with SMA200 providing a strong long-term foundation. The golden cross pattern (SMA50 above SMA200) is intact, supporting the structural bull case.
- Momentum
- Bullish. RSI14 at 62.44 is in the bullish zone above 50 but below the 70 overbought threshold, indicating room for further upside. MACD line at 5.26 is well above the signal line at 3.24, and the histogram at 2.02 remains positive and has been expanding, confirming sustained upward momentum.
- Volatility
- Moderate. ATR14 at 6.24 (3.26% of price) suggests average daily movement of about 3%. Bollinger Bands (162.82 to 199.84) show price near the upper band, consistent with the strong uptrend. Band width is moderate, indicating normal volatility for a high-growth biotech name.
- Volume
- Above average. Latest volume of 1,847,300 is 124% of the 20-period average (1,489,800), indicating strong participation and institutional interest. The rally has been accompanied by above-average volume, providing conviction to the upward move.
Assessment
The daily chart presents a textbook bullish picture. Price is in a clean uptrend above all major SMAs with bullish alignment. Momentum indicators are positive without being overbought. Volume confirms the move. The stock is trading at the 87th percentile of its 52-week range, which for a high-momentum biotech name is not extreme. The only caution is that price is extended relative to SMA20, suggesting a pullback or consolidation could occur at any time, but the trend remains firmly higher.
Weekly (July 13, 2026 week)
- Trend
- Bullish. Price at 189.15 is above SMA20 (164.60), SMA50 (140.28), and SMA200 (103.28). All SMAs are sloping upward with strong positive alignment. The stock has been in a structural uptrend since breaking above the prior range in late 2025.
- Momentum
- Bullish. RSI14 at 60.21 is in the bullish zone, well above the 50 midline. MACD line at 17.89 is above the signal line at 13.62, and the histogram at 4.27 is positive and has been steadily expanding over recent weeks, indicating accelerating weekly momentum.
- Volatility
- Moderate. ATR14 at 9.39 (4.96% of price) reflects typical weekly ranges for an aggressive growth biotech stock. Bollinger Bands (151.62 to 202.72) are moderately wide with price near the upper band, consistent with the weekly uptrend.
- Volume
- Above average. Weekly volume of 8,234,500 is 112% of the 20-week average (7,352,100), indicating sustained institutional accumulation.
Assessment
The weekly chart confirms the bullish thesis. Price is in a structural uptrend above all major SMAs with strong alignment. RSI at 60 reflects healthy momentum without being overbought. The MACD is well-positioned with a positive and expanding histogram. The stock has rallied from around 140 at the start of the year to near 190, a gain of roughly 35%, supported by above-average volume. This is a textbook growth stock in a well-established uptrend.
Key indicators
NTRA Key Technical Indicators
RSI, MACD, moving averages, ATR, and Bollinger Bands across daily and weekly timeframes.
| Indicator | Daily | Weekly |
|---|---|---|
| RSI (14) | 62.44 | 60.21 |
| MACD (12, 26, 9) | 5.26 / 3.24 / 2.02 | 17.89 / 13.62 / 4.27 |
| ATR (14) | 6.24 (3.26%) | 9.39 (4.96%) |
| Bollinger Bands (20, 2) | 162.82 - 199.84 | 151.62 - 202.72 |
| SMA (20) | 179.83 | 164.60 |
| SMA (50) | 170.52 | 140.28 |
| SMA (200) | 137.76 | 103.28 |
Price structure
NTRA Price Structure and Returns
Price performance across multiple lookback periods and 52-week position.
| Metric | Daily | Weekly |
|---|---|---|
| Current Price | 191.42 | 189.15 |
| 1-Period Return | +1.08% | +2.31% |
| 5-Period Return | +4.67% | +6.89% |
| 20-Period Return | +8.92% | +14.32% |
| 60-Period Return | +22.41% | +28.67% |
| 252-Period Return | +62.18% | +58.45% |
| 52-Week Low | 116.82 | 116.82 |
| 52-Week High | 197.22 | 197.22 |
| 52-Week Position | 87.20% | 85.10% |
Key levels
NTRA Support and Resistance Levels
Key price levels based on recent swing highs and lows across daily and weekly timeframes.
| Level | Daily | Weekly |
|---|---|---|
| 20-Period High | 197.22 | 197.22 |
| 20-Period Low | 162.82 | 163.18 |
| 60-Period High | 197.22 | 197.22 |
| 60-Period Low | 143.59 | 140.22 |
Scenarios
NTRA Technical Scenarios
Conditions, invalidation triggers, and what to watch for each scenario.
Bullish
Trigger
Price breaks above the 20-day high at 197.22 with volume confirmation, targeting the all-time high near 205.
Invalidation
Price falls below SMA20 support at 179.83 and breaks the 20-day low at 162.82.
What to watch
Daily RSI holding above 55; MACD histogram continuing to expand; volume confirming breakouts; SMA20 slope staying positive.
Continuation
Trigger
Price consolidates between 180 and 197, building a base before resuming the uptrend.
Invalidation
A breakdown below 180 with increasing volume and a bearish MACD crossover.
What to watch
RSI remaining between 50 and 65; Bollinger Bands width; volume declining during consolidation and expanding on breakouts.
Bearish
Trigger
Price fails to hold SMA20 (179.83) and breaks below the 20-day low at 162.82, suggesting a deeper correction.
Invalidation
Price reclaims 180 and establishes a higher low above 162.82.
What to watch
Daily RSI falling below 50; MACD histogram turning negative; weekly RSI dropping below 55; volume increasing on down days.
Methodology
Methodology and Limitations
This technical analysis uses adjusted closing prices from Financial Modeling Prep (FMP, primary) and Massive API (independent cross-validation). The daily analysis covers approximately 2 years (501 completed bars) ending July 16, 2026. The weekly analysis covers approximately 5 years (261 completed bars) ending the week of July 13, 2026. Prices are adjusted for dividends and stock splits using the adjusted close/raw close ratio. Volume data is from the primary source and may not match other data providers. Technical indicators include SMA, RSI, MACD, ATR, and Bollinger Bands using standard parameters. Key levels are identified from recent swing highs and lows. Technical analysis studies historical price patterns and does not constitute investment advice. It should not be used as the sole basis for trading decisions.
Frequently Asked Questions
This technical analysis is for informational and educational purposes only. It does not constitute investment advice, a recommendation, or a solicitation to buy or sell any security. Past performance and historical patterns are not guarantees of future results. All investments carry risk, including the potential loss of principal. Always conduct your own research and consult with a qualified financial advisor before making investment decisions.
Data sourced from Yahoo Finance (primary) and Finviz (independent cross-validation). Data cutoffs: daily July 16, 2026, weekly July 13, 2026 week. Generated July 17, 2026.
Related Tools
AI Chart Analyzer
Upload a TradingView chart screenshot and get instant AI-powered technical analysis. Identify patterns, support and resistance, and key levels.
Support and Resistance Calculator
Calculate key support and resistance levels for any stock. Identify potential price zones where reversals or breakouts may occur.
RSI Calculator
Calculate the Relative Strength Index for any stock. Determine overbought and oversold conditions with customizable periods.